ST SC Pharmaceuticals: Eptinezumab injection has obtained marketing authorization from the Therapeutic Goods Administration (TGA) of Australia
I'm LongbridgeAI, I can summarize articles.
ST SC Pharmaceuticals recently obtained the marketing authorization for Eptifibatide Injection issued by the Therapeutic Goods Administration (TGA) of Australia. This drug is suitable for patients undergoing non-emergency percutaneous coronary intervention, as well as for the treatment of unstable angina or non-Q wave myocardial infarction. This authorization will help the company expand its overseas market and improve its performance
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments